{"meshTagsMajor":["Bile Ducts, Intrahepatic"],"meshTags":["Female","Survival Rate","Bile Ducts, Intrahepatic","Bile Duct Neoplasms","Prognosis","Endoscopy, Digestive System","Humans","Treatment Outcome","Male","Cholangiocarcinoma","Cholangiography"],"meshMinor":["Female","Survival Rate","Bile Duct Neoplasms","Prognosis","Endoscopy, Digestive System","Humans","Treatment Outcome","Male","Cholangiocarcinoma","Cholangiography"],"organisms":["6192"],"publicationTypes":["Journal Article","Review"],"abstract":"Cholangiocarcinoma constitutes the second most common primary liver cancer after hepatocellular carcinoma. It is particularly prevalent in regions where liver flukes are hyperendemic. Obstructive jaundice is the most common presentation. To evaluate patients suspected for cholangiocarcinoma, endoscopy is becoming more popular. Endoscopy can provide important information especially cholangiogram and tissue diagnosis. Recently, the role of endoscopy has not only been used for diagnosis but also for treatment. In this article, the roles of endoscopy for diagnosis, therapy, and future modality of treatment for cholangiocarcinoma are provided.","title":"Endoscopic management of cholangiocarcinoma.","pubmedId":"11529373"}